ArticleFuture oncology (London, England)2025
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-,
Matthew P Goetz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleFuture oncology (London, England)2025
Matthew P Goetz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.